September 16, 2023 Comments Off on New patent for Neurocrine drug INGREZZA Posted in: Patent Added Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are twenty patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on…
September 16, 2023 Comments Off on Which pharmaceutical drugs have the most drug patents in Russian Federation? Posted in: Infographic This chart shows the drugs with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical drugs have the most drug patents in Russi…